Yirui Pharma Announces Successful Completion of U.S. Phase I Clinical Trial for YR001

-
Mar 2
Hangzhou Yirui Pharmaceutical Technology Co., Ltd. (hereinafter referred to as “Yirui Pharma”) announced […]
Read Article